Clinical significance of Helicobacter pylori infection in patients with acute coronary syndromes: an overview of current evidence. (Q38211000)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24817551%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

title

Clinical significance of Helicobacter pylori infection in patients with acute coronary syndromes: an overview of current evidence (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24817551%20AND%20SRC:MED&resulttype=core&format=json

Helicobacter pylori infectious disease

18 March 2020

main subject

Helicobacter pylori

0 references

1 reference

inferred from title

acute coronary syndrome

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24817551%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Maria Kłopocka

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24817551%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Jacek Kubica

5

0 references

Marek Koziński

series ordinal

2

object named as

Marek Koziński

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24817551%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

author name string

Julia Maria Kubica

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24817551%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

publication date

10 May 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24817551%20AND%20SRC:MED&resulttype=core&format=json

Clinical Research in Cardiology

18 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24817551%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

volume

103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24817551%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

page(s)

855-886

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24817551%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24817551%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00392-014-0720-4

18 March 2020

exact match

0 references

cites work

Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Inflammation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Value of C-reactive protein as a risk factor for acute coronary syndrome: a comparison with apolipoprotein concentrations and lipid profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Percutaneous coronary intervention triggers a systemic inflammatory response in patients treated for in-stent restenosis -- comparison with stable and unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Interaction between Helicobacter pylori, diet, and genetic polymorphisms as related to non-cancer diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Helicobacter pylori seroprevalence in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Gastrointestinal bleeding after percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Effects of Helicobacter pylori infection on long-term risk of peptic ulcer bleeding in low-dose aspirin users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Systematic review: Helicobacter pylori and the risk of upper gastrointestinal bleeding risk in patients taking aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Effects of Helicobacter pylori eradication on platelet activation and disease recurrence in patients with acute coronary syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Cross-sectional study: CagA-positive Helicobacter pylori infection, acute coronary artery disease and systemic levels of B-type natriuretic peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Anti-Helicobacter pylori actions of CV-6209, a platelet-activating factor receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Genetic determinants of platelet response to clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Relation of Helicobacter pylori infection and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Helicobacter and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Prognostic role of Helicobacter pylori infection in acute coronary syndrome: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Coronary atherosclerotic burden in patients with infection by CagA-positive strains of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Relation of Helicobacter pylori infection to 13-year mortality and incident ischemic heart disease in the caerphilly prospective heart disease study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Coronary heart disease, Helicobacter pylori, dental disease, Chlamydia pneumoniae, and cytomegalovirus: meta-analyses of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Seroincidence of Helicobacter pylori infection in a cohort of rural Bolivian children: acquisition and analysis of possible risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Prevalence of Helicobacter pylori infection in coronary artery disease and effect of its eradication on coronary lumen reduction after percutaneous coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Possible pathogenetic role of Helicobacter pylori infection in cardiac syndrome X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Frequency of Helicobacter pylori and cytotoxine associated gene A antibodies in patients with cardiac syndrome X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

The favourable effect of Helicobacter pylori eradication therapy in patients with recurrent angina-like chest pain and non-responsive to proton pump inhibitors - a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Association of Helicobacter pylori infection with coronary heart disease. Association may not be causal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Stent implantation, but not pathogen burden, is associated with plasma C-reactive protein and interleukin-6 levels after percutaneous coronary intervention in patients with stable angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Association of virulent Helicobacter pylori strains with ischemic heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Significant association of cagA positive Helicobacter pylori strains with risk of premature myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Ischaemic heart disease and Cag A strains of Helicobacter pylori in the Caerphilly heart disease study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Prevalence of Helicobacter pylori infection and its link to coronary risk factors in Japanese patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Prospective analysis of the association of infection with CagA bearing strains of Helicobacter pylori and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Helicobacter pylori active infection in patients with acute coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Acute coronary syndrome and chronic infection in the Cork coronary care case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

The association between current Helicobacter pylori infection and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

The combination of Helicobacter pylori- and cytotoxin-associated gene-A seropositivity in relation to the risk of myocardial infarction in middle-aged Japanese: The Japan Public Health Center-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Prevalence of Helicobacter pylori positivity in patients undergoing percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Cytomegalovirus, Chlamydia pneumoniae, and Helicobacter pylori IgG antibodies and restenosis after stent implantation: an angiographic and intravascular ultrasound study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Prior cytomegalovirus, Chlamydia pneumoniae or Helicobacter pylori infection and the risk of restenosis after percutaneous transluminal coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes: South Thames Trial of Antibiotics in Myocardial Infarction and Unstable Angina (STAMINA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Effect of 3 months of antimicrobial treatment with clarithromycin in acute non-q-wave coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary Syndrome (AZACS) trial: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

A review of the postulated mechanisms concerning the association of Helicobacter pylori with ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

H pylori infection and systemic antibodies to CagA and heat shock protein 60 in patients with coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Association of Chlamydia pneumoniae and Helicobacter pylori infection with angiographically demonstrated coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Detection of Chlamydia pneumoniae and Helicobacter pylori in atherosclerotic plaques of carotid artery by polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

No detection of Helicobacter pylori in atherosclerotic plaques in end stage renal disease patients undergoing kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

H pylori seropositivity and cytokine gene polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Prevalence of cardiovascular diseases in HIV-infected outpatients: results from a prospective, multicenter cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Pathogen burden, inflammation, proliferation and apoptosis in human in-stent restenosis. Tissue characteristics compared to primary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Prognostic value of NT-pro-BNP and hs-CRP for risk stratification in primary care: results from the population-based DETECT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

The putative role of the intestinal microbiota in the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Fundamentals of neurogastroenterology: basic science

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Evaluation of stress systems by applying noninvasive methodologies: measurements of neuroimmune biomarkers in the sweat, heart rate variability and salivary cortisol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Neuropathophysiology of functional gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Autonomic nervous function in Helicobacter pylori-infected patients with atypical chest pain studied by analysis of heart rate variability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Does eradication of Helicobacter pylori infection help normalize serum lipid and CRP levels?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Influence of Helicobacter pylori infection and eradication on blood lipids and fibrinogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

VacA, the vacuolating cytotoxin of Helicobacter pylori, binds to multimerin 1 on human platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle aged men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

The role of autonomic neuropathy as a risk factor of Helicobacter pylori infection in dyspeptic patients with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Association between Helicobacter pylori infection and diabetes mellitus: a meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Prevalence and risk factors of Helicobacter pylori in Turkey: a nationally-representative, cross-sectional, screening with the ¹³C-Urea breath test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Association of Helicobacter pylori infection with diabetes mellitus and diabetic nephropathy: a meta-analysis of 39 studies involving more than 20,000 participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Seroprevalence of hepatitis E and Helicobacter pylori in a low socioeconomic area of a metropolitan city in a developing country

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Helicobacter pylori infection: relation with cardiovascular risk factors, ischaemic heart disease, and social class

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Helicobacter pylori: epidemiology and routes of transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

A prospective study of Helicobacter pylori seropositivity and the risk for future myocardial infarction among socioeconomically similar U.S. men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Helicobacter pylori and Chronic ITP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

The effect of different strains of Helicobacter pylori on platelet aggregation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Blood group O and vWf expression may be involved in development of peptic ulcer disease secondary to Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Cross-reaction of antibody against Helicobacter pylori urease B with platelet glycoprotein IIIa and its significance in the pathogenesis of immune thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

P-selectin-dependent platelet aggregation and apoptosis may explain the decrease in platelet count during Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Helicobacter pylori urease activates blood platelets through a lipoxygenase-mediated pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Platelet activation in Helicobacter pylori-associated idiopathic thrombocytopenic purpura: eradication reduces platelet activation but seldom improves platelet counts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

The risk of adverse cardiac and bleeding events following noncardiac surgery relative to antiplatelet therapy in patients with prior percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Noncardiac surgery and bleeding after percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Gastric mucosal damage evaluated by transnasal endoscopy and QOL assessments in ischemic heart disease patients receiving low-dose aspirin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Acid suppressants reduce risk of gastrointestinal bleeding in patients on antithrombotic or anti-inflammatory therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Comorbidities affect risk of nonvariceal upper gastrointestinal bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Ability of rabeprazole to prevent gastric mucosal damage from clopidogrel and low doses of aspirin depends on CYP2C19 genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Clopidogrel with or without omeprazole in coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Does long-term aspirin use have any effect on Helicobacter pylori eradication?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Applications of CYP450 testing in the clinical setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

The long-term impact of Helicobacter pylori eradication on gastric histology: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Drug-coated balloons in treatment of in-stent restenosis: a meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Evaluation of three different tests for the detection of stool antigens to diagnose Helicobacter pylori infection in patients with upper gastrointestinal bleeding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Risk factors for severe nonsteroidal anti-inflammatory drug-induced small intestinal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Role of small intestinal bacterial overgrowth in severe small intestinal damage in chronic non-steroidal anti-inflammatory drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Infection With Helicobacter pylori Is Not a Major Independent Risk Factor for Stable Coronary Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0720-4

Detection of cytomegalovirus and Helicobacter pylori DNA in arterial walls with grade III atherosclerosis by PCR.

21 January 2018

1 reference

12 December 2020

Virulent strains of Helicobacter pylori and vascular diseases: a meta-analysis

1 reference

12 December 2020

Lipid profile and Helicobacter Pylori infection

1 reference

12 December 2020

Helicobacter pylori infection and diabetes mellitus: the 2013 state of art.

1 reference

12 December 2020

CagA-positive Helicobacter pylori strains enhanced coronary atherosclerosis by increasing serum OxLDL and HsCRP in patients with coronary heart disease

1 reference

12 December 2020

Is Helicobacter pylori infection a risk factor for acute coronary syndromes?

1 reference

12 December 2020

Antibody levels against Chlamydia pneumoniae and outcome of roxithromycin therapy in patients with acute myocardial infarction. Results from a sub-study of the randomised Antibiotic Therapy in Acute Myocardial Infarction (ANTIBIO) trial

1 reference

12 December 2020

Helicobacter pylori infection and coronary artery disease

1 reference

12 December 2020

The relationship between helicobacter pylori infection and myocardial infarction.

1 reference

12 December 2020

ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and

1 reference

12 December 2020

Interaction of Helicobacter pylori infection and low-dose aspirin in the upper gastrointestinal tract: implications for clinical practice

1 reference

12 December 2020

Randomised clinical trial: simvastatin as adjuvant therapy improves significantly the Helicobacter pylori eradication rate--a placebo-controlled study

1 reference

12 December 2020

Potential link between Helicobacter pylori and ischemic heart disease: does the bacterium elicit thrombosis?

1 reference

12 December 2020

Factors associated with Helicobacter pylori infection, results from a developing country - Pakistan

1 reference

12 December 2020

Association of helicobacter pylori infection with severity of coronary heart disease

1 reference

12 December 2020

Helicobacter pylori seropositivity in patients with acute coronary syndromes

1 reference

12 December 2020

Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atheros

1 reference

12 December 2020

A comparison of the acid-inhibitory effects of esomeprazole and rabeprazole in relation to pharmacokinetics and CYP2C19 polymorphism

1 reference

12 December 2020

Effect of coronary angioplasty on Helicobacter pylori IgG antibody: lack of association between high sensitive C reactive protein and Helicobacter pylori IgG antibody levels

1 reference

12 December 2020

Is helicobacter pylori infection a risk factor for coronary heart disease?

1 reference

12 December 2020

Acute myocardial infarction and Helicobacter pylori seropositivity

1 reference

12 December 2020

Personalized treatment in the eradication therapy for Helicobacter pylori

1 reference

12 December 2020

Combined periprocedural evaluation of CRP and TNF-alpha enhances the prediction of clinical restenosis and major adverse cardiac events in patients undergoing percutaneous coronary interventions

1 reference

12 December 2020

Possible role of Helicobacter pylori infection via microvascular dysfunction in cardiac syndrome X.

1 reference

12 December 2020

Association of Helicobacter pylori infection with acute myocardial infarction

1 reference

12 December 2020

Clinical and biochemical parameters related to cardiovascular disease after Helicobacter pylori eradication

1 reference

12 December 2020

Is there an association between Helicobacter pylori infection and coronary heart disease?

1 reference

12 December 2020

CagA antigen of helicobacter pylori and coronary instability: Insight from a clinico-pathological study and a meta-analysis of 4241 cases

1 reference

12 December 2020

Low socioeconomic status increases short-term mortality of acute myocardial infarction despite universal health coverage

1 reference

12 December 2020

[An overview of methods dedicated to protection of the digestive tract in patients treated with aspirin. Focus on clinical effectiveness and antiplatelet properties]

1 reference

12 December 2020

Detection of Helicobacter pylori and Chlamydia pneumoniae DNA in human coronary arteries and evaluation of the results with serologic evidence of inflammation

1 reference

12 December 2020

Prospective study of potentially virulent strains of Helicobacter pylori and coronary heart disease in middle-aged men

1 reference

12 December 2020

Antithrombotic therapy in anticoagulated patients with atrial fibrillation presenting with acute coronary syndromes and/or undergoing percutaneous coronary intervention/stenting

1 reference

12 December 2020

Individualised PPI prescription in patients on combination antiplatelet therapy and upper gastrointestinal events after percutaneous coronary intervention: a cohort study

1 reference

12 December 2020

The association between infection burden in Iranian patients with acute myocardial infarction and unstable angina

1 reference

12 December 2020

Helicobacter pylori stool antigen test in patients with bleeding peptic ulcers

1 reference

12 December 2020

Relationship between Helicobacter pylori infection and serum interleukin-18 in patients with carotid atherosclerosis

1 reference

12 December 2020

13C-Urea breath test for the diagnosis of Helicobacter pylori infection

1 reference

12 December 2020

Detection of Helicobacter pylori DNA in aortic and left internal mammary artery biopsies

1 reference

12 December 2020

A role for immunoglobulin G in donor-specific Streptococcus sanguis-induced platelet aggregation

1 reference

12 December 2020

Roxithromycin in prevention of acute coronary syndrome associated with Chlamydia pneumoniae infection: a randomized placebo controlled trial

1 reference

12 December 2020

[Effect of Helicobacter pylori infection on platelet activation and coagulation function in patients with acute cerebral infarction]

1 reference

12 December 2020

Cytotoxin-associated gene-A-seropositive virulent strains of Helicobacter pylori and atherosclerotic diseases: a systematic review

1 reference

12 December 2020

Pantoprazole may enhance antiplatelet effect of enteric-coated aspirin in patients with acute coronary syndrome.

1 reference

12 December 2020

10.1007/S00392-014-0720-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24817551%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference